Joshua Kazam is a co-founder and director of IconOVir Bio. Josh is also a co-founder and director of Kronos Bio, Inc. (KRON), and Allogene Therapeutics, Inc. (ALLO), and is a co-founder and Partner of Two River, where he has served as partner since its inception in 2004. He is a co-founder and partner of Vida Ventures, LLC, a life science venture group with offices in Boston, San Francisco and Los Angeles., and was a co-founder and director of Kite Pharma, Inc., where he served on the Board of Directors from inception until its acquisition by Gilead Sciences, Inc. in 2017. Joshua also serves as a director of several privately held companies including Vision Path, Inc. (d/b/a Hubble Contacts), ByHeart Inc, Breakthrough Properties, LLC and Breakthrough Services LLC.
Joshua is a Member of the Wharton School’s Undergraduate Executive Board and serves on the Board of the Desert Flower Foundation. He received his bachelor’s degree in Entrepreneurial Management from the Wharton School of Business at the University of Pennsylvania.